Article
ER+/PR- phenotype exhibits more aggressive biological features and worse outcome compared with ER+/PR+ phenotype in HER2-negative inflammatory breast cancer.
Scientific reports - 2 Jan 2024
Luo Yunbo, Li Qingyun, Fang Jiang, Pan Chaoying, Zhang Lingxing, Xu Xia, Qian Shuangqiang, Zhao Xiaobo, Hou Lingmi
Abstract excerpt
The loss of progesterone receptor (PR) often predicts worse biological behavior and prognosis in estrogen receptor-positive (ER +) breast cancer. However, the impact of PR status on inflammatory breast cancer (IBC) has not been studied. Therefore, the purpose of our study was to investigate the influence of PR on IBC. Patients with ER+ and HER2-negative IBC were selected from the Surveillance, Epidemiology and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
